Clinical Trial Detail

NCT ID NCT01331616
Title Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors West Penn Allegheny Health System
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.